Neurocore And The Use Of Neurotherapy To Treat Depression

Neurocore Brain Performance Centers focuses on providing brain-based assessment as well as training programs in order do help adults and children to improve concentration, manage stress, and improve sleep. The company was founded in 2004 and became an important national figure when it comes to applied neuroscience, having 9 brain performance centers in Florida and Michigan. Read more about Neurocore at

Advances have developed in EEG technology, neurofeedback, and brain mapping, giving scientist a better understanding on how the brain functions, and what can be done in order to improve its functioning. Neurocore started applying this knowledge in order to improve mental acuity but also to help treat mental disorders such as depression, anxiety, ASD, and ADHD. Despite the fact that such neurotherapeutic applications have only been available to the public at large only recently, they actually have a rich history that dates back to the middle of the 20th century.

Neurotherapy, which is also known as neurofeedback, is the practice of using electrical measurements of the brain waves in order to teach the brain to regulate itself. In 1968, Joe Kamiya published an article in Pshycology Today, which helped popularize neurotherapy – an article which stands out as being the first to provide EEG neurofeedback training. Frederick Lemere is also an important figure in the field of Neurotherapy, as he is responsible for publishing a description that linked depression to EEG results, in 1936.


Lemere’s research is used today by clinicians and scientist at Neurocore in order to offer patients a Medication-Free Depression Treatment Program that uses neurofeedback. The patients of Neurocore are using neurofeedback to help train their brains overcome the severity of symptoms that depression has, and in some cases overcome the disorder altogether. The brain training therapy that Neurocore offers starts with a comprehensive assessment that employs the use of qEEG brainwave mapping technology, among other diagnostic measures that can help generate a clear picture of the patient’s depression symptoms. 292 clients completed Neuocore’s 30-session program, and out of the 292, 51% do not meet the symptomatic threshold for the disorder any more, and 84% have experienced a noticeable reduction of the symptoms. Visit to know more about Neurocore.